1. Home
  2. ABCL vs MLKN Comparison

ABCL vs MLKN Comparison

Compare ABCL & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$9.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo MillerKnoll Inc.

MLKN

MillerKnoll Inc.

HOLD

Current Price

$24.04

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
MLKN
Founded
2012
1905
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
ABCL
MLKN
Price
$9.44
$24.04
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$8.40
N/A
AVG Volume (30 Days)
6.1M
660.2K
Earning Date
05-11-2026
03-25-2026
Dividend Yield
N/A
4.71%
EPS Growth
10.91
344.44
EPS
N/A
1.32
Revenue
$75,128,000.00
$3,841,700,000.00
Revenue This Year
N/A
$5.94
Revenue Next Year
$21.85
$3.78
P/E Ratio
N/A
$18.28
Revenue Growth
160.56
4.68
52 Week Low
$2.75
$13.77
52 Week High
$10.01
$24.71

Technical Indicators

Market Signals
Indicator
ABCL
MLKN
Relative Strength Index (RSI) 77.04 63.91
Support Level $3.38 $18.05
Resistance Level N/A N/A
Average True Range (ATR) 0.51 0.81
MACD 0.29 -0.00
Stochastic Oscillator 87.97 79.83

Price Performance

Historical Comparison
ABCL
MLKN

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

Share on Social Networks: